Androvia LifeSciences LLC
Category: Diagnostics
Campus: Ithaca
Incubator:
Androvia LifeSciences is a NY-based, privately held company focused on developing new diagnostics that provide a higher level of patient management of male fertility for use by clinicians to counsel couples. The company’s objective is to understand male fertility at its most fundamental level – how it occurs, how it’s measured, and how it can be applied to improve outcomes.
Location: Ithaca, NY
Foundation Cornell Technology Licensed: 2015
C2i Genomics
Category: Diagnostics
Campus: Weill Cornell Medicine
Incubator:
C2i Genomics helps doctors and patients fight cancer by providing doctors and patients with tumor burden information, starting with only a blood sample. Its service, called C2, uses software that performs pattern recognition on data from whole-genome sequencing of the blood sample. Physicians can use the service to monitor their patient’s response to treatment and detect treatment failure or disease recurrence well before they would do otherwise. Physicians can also use the service to measure treatment response in clinical trials.
Location: New York, NY
Foundation Cornell Technology Licensed: 2020
Elucida Oncology, Inc.
Category: Diagnostics
Campus: Ithaca
Incubator:
Elucida Oncology, Inc. is developing technology for the treatment and diagnostic imaging of oncological diseases.
Location: New York, NY
Foundation Cornell Technology Licensed: 2015
Esper BioSciences, Inc.
Category: Diagnostics
Campus: Ithaca
Incubator: Center for Life Science Ventures
Esper Biosciences aims to develop a low-cost, high-speed DNA sequencer, for use in point-of-care medical diagnostics and scientific research.
Location: Ithaca, NY
Foundation Cornell Technology Licensed: 2017
GIANT Biosystems, Inc.
Category: Diagnostics
Campus:
Incubator:
GIANT BioSystems, founded by a team of elite scientists from leading institutions such as Cornell, Caltech, Harvard, UCLA, and MIT (Dr. Ehsan Shirzaei Sani, CEO/Co-Founder; Dr. Morteza Azizi, CTO/Co-Founder; Canran Wang, COO/Co-Founder; and Samuel Solomon, CSO/Director of AI), is pioneering an AI/ML-assisted microfluidics-based platform for high-throughput antimicrobial susceptibility testing (AST) and drug/antibiotic discovery. GIANT’s patented microfluidics chip facilitates the simultaneous screening of over 50 antibiotics in just 3-5 hours with exceptional precision. The GIANT platform is cost-effective, compact, highly precise, and user-friendly, requiring no complex training.
Location: Los Angeles, California
Foundation Cornell Technology Licensed:
Immunovent, LLC
Category: Diagnostics
Campus: Weill Cornell Medicine
Incubator:
Immunovent, LLC is focused on the commercialization of next-generation technologies for allergy diagnosis. The company is developing the Local Allergy Mucosal Brush Test (LAMB-Dx), the first quantitative allergy diagnostic that will enable physicians to accurately test for both airborne and food allergies precisely where the clinical symptoms are occurring – in the mouth and nose.
Location: New York, NY
Foundation Cornell Technology Licensed: 2014
Kanvas Bioscience, Inc.
Category: Diagnostics
Campus: Ithaca
Incubator: Center for Life Science Ventures
Kanvas Biosciences, Inc. has developed an approach to identify dense microbial organisms at a single-microbe resolution through spatially resolved metagenomics and a combination of multi-spectral imaging and innovative software. This technology circumvents metagenomic sequencing and can be applied as a diagnostic to identify microbial communities or study tumor-microbiome relationships.
Location: Ithaca, NY
Foundation Cornell Technology Licensed: 2021
Lo Bio Life Sciences LLC
Category: Diagnostics
Campus: Ithaca
Incubator:
Lo Bio has developed a rapid and low-cost approach to separate red blood cells from plasma using magnetic beads and a portable separator. This approach yields highly pure plasma from small volumes, takes less than two minutes, and can be applied for diagnostic tests for COVID-19, HIV 1 / 2, and HCV.
Location: Rockville, Maryland
Foundation Cornell Technology Licensed: 2021
NeuroMedica, Inc.
Category: Diagnostics
Campus: Weill Cornell Medicine
Incubator:
NeuroMedica is developing a revolutionary endovascular flow diverter and coil-containment device for the minimally invasive treatment of bifurcation aneurysms.
Location: Johns Island, SC
Foundation Cornell Technology Licensed: 2018
